Confidentiality Notice. Access to this calculator is restricted to parties under executed NDA. Pricing structures and net revenue data are proprietary to TEHR. Any sharing, screenshotting, or external distribution of this content is prohibited.
TEHROnboarding
Step 2 of 10
About TEHR
Every telehealth brand you envy runs on infrastructure you cannot see. TEHR is that infrastructure: the provider network, e-prescribing with EPCS, a national compounding and commercial pharmacy stack, compliant payment rails, and the operational machine that binds them together. All of it wearing your brand. Your patients never see us. Your competitors never catch you.
While others spend a year and seven figures building what breaks, you launch in 24 hours on rails that already move real prescriptions every day. You keep your identity. You keep your patients. You keep your economics. We make the machine run.
The brands winning this market did not build harder. They built on better rails.
What happens next
Eight steps. You can stop at any point and pick up where you left off.
What you are unlocking
Verified operators build from these. Verification takes about a minute.
🔒
Locked until your identity is verified
Verify once, then build.
Step 3 of 10
Verify your identity
We are a prescribing platform, so we confirm that the person opening an account is who they say they are. Verification is handled entirely by Stripe Identity: TEHR never receives or stores your ID images. Nothing is asked of you financially at this step.
Government ID and selfie Not started
A photo of your ID plus a selfie that has to match it. Takes about a minute.
Step 4 of 10
Mutual confidentiality
Step 5 of 10
Build your plan
This is your pricing page. Each vertical is a complete, ready-to-sell product line
— medications, protocols and patient pricing, curated and compliant out of the box.
Your selection sets your monthly, and the running total stays on screen as you build.
Saving also builds your starting catalog from each vertical’s blueprint. Nothing is
charged here; you can change any of it before you activate.
Full Custom: build it with us
Open the full network and mark everything you want to sell. You are choosing medications, not suppliers — sourcing is ours to solve, and solving it is why we can route each line to its best available source rather than whichever pharmacy you happened to pick.
When your list is ready, send it over. A person reviews every line for margin, state restrictions and clinical fit, then prices the catalog as a whole. It sits in your cart as pending until that is done, and activation waits for it.
Step 6 of 10
Check your numbers
One input. We model your saved catalog at the prices you set.
Projected annual net revenue
--
Net per patient per year
--
At your saved catalog prices
⚠ Modeling-only disclaimer
This is a forward-looking revenue projection based on assumptions you've supplied (patient pricing, cycle frequency, churn rate, growth rate). Actual results depend on patient acquisition costs, market conditions, operator execution, regulatory factors, and many variables not modeled here.
Projections are for planning purposes only and constitute neither a guarantee nor a representation of expected returns. Output is not for redistribution.
Step 7 of 10
Company profile
Step 8 of 10
Set your policies
Step 9 of 10
Review and sign
Step 10 of 10
Activate
One operation: your subscription is created, one-time items are added to its first invoice, and the card you saved at step 3 is charged. Amounts come from Stripe at the moment you activate.
What you are activating
Payment method Required
The card below is charged once, now, for the total above. Your subscription then renews monthly.
Before we can activate
Your first invoice
TEHRNet Revenue Calculator
Onboarding
Note: The net you see is the net you keep: every figure already includes TEHR's flat per-transaction platform fee, and platform fees are never a percentage of your revenue. Figures are modeling estimates based on standard cost assumptions; final economics depend on contract structure, operating states, and patient mix. Shipping is modeled at a standard rate; actual shipping rates vary by season, parcel weight, destination, and cold-chain requirements.
Welcome. One signature before we open the room.
Everything inside (catalogs, pricing, projections) is confidential. Sixty seconds, and it protects your future business as much as ours.
MUTUAL NON-DISCLOSURE AGREEMENT
This Mutual Non-Disclosure Agreement (“Agreement”) is entered into by and between the organization identified in the signature block below, for itself and on behalf of its Affiliates (collectively, “Counterparty”), and TEHR LLC for itself and on behalf of its Affiliates, including TRIMUS (collectively, “TEHR”) (Counterparty and TEHR each, a “Party” and collectively, the “Parties”), effective as of the date of the last signature below (“Effective Date”).
Accepted and agreed to as of the Effective Date by the authorized representative of each Party:
1. Purpose. The Parties desire to protect the confidentiality of certain confidential information of each Party to be disclosed under this Agreement solely for use in evaluating or pursuing a potential business relationship between the Parties or their Affiliates or fulfilling the objectives of such business relationship (“Permitted Use”).
2. Definition. Subject to the exceptions in Section 5, “Confidential Information” means information disclosed by a Party or its Affiliates (“Disclosing Party”), including by its agents, consultants, and professional advisors, to the other Party or its Affiliates (“Receiving Party”), including, but not limited to, trade secrets, techniques, models, inventions, know-how, processes, sketches, algorithms, data, software, hardware, terms of agreements, negotiations or proposals, financial, business, user, sales, clinical, regulatory, patient, provider, or technical information, and such other information disclosed (a) in written or other tangible form and marked “Confidential” or with words of similar import; (b) orally or visually and identified as confidential or proprietary information at the time of disclosure; or (c) under circumstances by which the Receiving Party should reasonably understand such information is to be treated as confidential, whether or not marked “Confidential.”
3. Non-Use and Non-Disclosure Obligations. Subject to Section 5, the Receiving Party agrees that it will hold in strict confidence and not disclose Confidential Information to any individual or third party except to the Receiving Party’s employees, directors, officers, independent contractors, agents, consultants, and professional advisors (collectively, “Authorized Recipients”) who have a need to know or as expressly approved in writing by the Disclosing Party, and will use Confidential Information for no purpose other than the Permitted Use. The Receiving Party will also protect Confidential Information with at least the same degree of care that the Receiving Party uses to protect its own confidential information, but in no case less than reasonable care. The Receiving Party will limit access to Confidential Information to only those Authorized Recipients having a need to know and who have signed confidentiality agreements containing, or are otherwise bound by, confidentiality obligations at least as restrictive as those contained herein. The Receiving Party will not modify, reverse engineer, disassemble, or decompile Confidential Information unless otherwise authorized in writing by the Disclosing Party. The Receiving Party will not reproduce Confidential Information in any form except as required for the Permitted Use. Any reproduction by a Receiving Party of any Confidential Information will remain the property of the Disclosing Party and will preserve all confidential or proprietary notices or legends that appear on the original unless otherwise authorized in writing by the Disclosing Party. The Receiving Party will be responsible for any unauthorized use or disclosure of Confidential Information by its Authorized Recipients. The Receiving Party will promptly notify the Disclosing Party in writing upon discovery of any loss or unauthorized disclosure of Confidential Information and cooperate with the Disclosing Party to investigate and mitigate any adverse effects. Each Party will comply with all applicable export and sanctions laws and regulations as they pertain to the use and disclosure of Confidential Information.
4. No Publicity. Each Party agrees that it may not make any public disclosures relating to the existence or terms of this Agreement or use the other Party’s name in any publication, promotional material, or other written or oral statement for public distribution, except with the other Party’s prior written consent or as may otherwise be required by law, rule, or regulation.
5. Exceptions. The Receiving Party will not have any obligations under this Agreement with respect to a specific portion of the Confidential Information if such Receiving Party can demonstrate with competent evidence that such portion of Confidential Information: (a) is or becomes publicly known through no wrongful act or omission of the Receiving Party; (b) is rightfully communicated to the Receiving Party from a third party without obligation of confidentiality; (c) is approved for release by written authorization of the Disclosing Party; (d) is already in the possession of, or lawfully known by, the Receiving Party at the time of disclosure by the Disclosing Party; or (e) was developed by the Receiving Party independently and without the use of any Confidential Information. The Receiving Party may disclose certain Confidential Information without violating the obligations of this Agreement to the extent such disclosure is required by applicable law, regulation, or a valid order of a court or other governmental body having jurisdiction provided that the Receiving Party: (x) provides the Disclosing Party with reasonable prior written notice of such disclosure (to the extent legally permitted); (y) gives the Disclosing Party an opportunity to challenge or limit the disclosure requirement or seek an appropriate protective order; and (z) reasonably cooperates with the Disclosing Party to narrow the scope of such disclosure to only that portion of the Confidential Information that is necessary to fulfill the order or requirement.
6. Return or Destruction. Upon written request of the Disclosing Party, the Receiving Party will promptly return to the Disclosing Party or destroy all documents and other tangible materials representing the Disclosing Party’s Confidential Information, provided, however, that the Receiving Party may retain and use such Confidential Information if and to the extent permitted by a license or similar right under a separate agreement. Notwithstanding the foregoing, each Party will be permitted to retain copies of the other Party’s Confidential Information solely for archival, audit, legal, and/or regulatory purposes provided that any Confidential Information so retained will: (a) remain subject to the obligations and restrictions contained in this Agreement; and (b) be retained in a manner consistent with the retaining Party’s routine document retention policies and procedures.
7. No Implied Right or Relationship. Confidential Information is and will remain the sole property of the Disclosing Party, and no license or other right to Confidential Information or intellectual property is granted or implied in this Agreement or by any disclosure. Neither this Agreement nor the disclosure of any Confidential Information hereunder will result in any obligation on the part of either Party to enter into any further agreement with the other, license any products or services to the other, or require either Party to disclose any particular Confidential Information. Nothing in this Agreement creates or will be deemed to create any employment, joint venture, or agency relationship between the Parties.
8. Term. The term of this Agreement will begin on the Effective Date and expire upon the earlier of (i) 2 years thereafter; or (ii) the date the Parties enter into a separate written definitive agreement with confidentiality obligations regarding the Permitted Use. Either Party may terminate this Agreement at any time upon 30 calendar days’ written notice to the other Party. Unless otherwise agreed in writing by the Parties, the obligations with respect to the non-use, non-disclosure, and protection of Confidential Information received during the term of this Agreement will survive for a period of 5 years after any expiration or termination of this Agreement. Notwithstanding the foregoing, the Receiving Party’s obligations of non-use, non-disclosure, and protection with respect to any Confidential Information that constitutes a trade secret under applicable law will survive any expiration or termination of this Agreement and continue for as long as such information remains a trade secret under applicable law.
9. No Warranty. The Disclosing Party provides Confidential Information on an “AS-IS” basis for use by the Receiving Party at its own risk. The Disclosing Party disclaims all warranties to its Confidential Information, whether express, implied, or statutory, including as to accuracy, performance, completeness, and suitability.
10. Affiliate. “Affiliate” of a Party means an entity that, directly or indirectly, controls, is controlled by, or is under common control with such Party, where “control” means the power to direct or cause the direction of an entity’s management or affairs through ownership or control of 50% or more of the voting equity securities or other equivalent voting interest of an entity.
11. Governing Law; Jurisdiction, and Venue. This Agreement and any dispute or claim arising out of or relating to it (including non-contractual disputes or claims) shall be governed by, and construed in accordance with, the laws of the State of Delaware without regard to conflict-of-laws principles. The Parties irrevocably agree that the state and federal courts located in New Castle County, Delaware shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this Agreement, and each Party hereby irrevocably submits to the exclusive jurisdiction and venue of such courts and waives any objection to such jurisdiction or venue on the grounds of inconvenient forum or otherwise.
12. Remedies. Each Party acknowledges that its or any of its Authorized Recipients’ breach of this Agreement may cause irreparable damage to the other Party and hereby agrees that the other Party will be entitled to seek injunctive relief under this Agreement, as well as such further relief as may be granted by a court of competent jurisdiction.
13. Miscellaneous. This Agreement is the complete, final, and exclusive agreement of the Parties with respect to the subject matters hereof and supersedes all prior and contemporaneous discussions between the Parties with respect to such matters. No modification of or amendment to this Agreement will be effective unless in writing and signed by all Parties. If any provision of this Agreement is held by a court of competent jurisdiction to be illegal, invalid, or unenforceable under any present or future law, (a) such provision shall be limited, construed, or reformed to the minimum extent necessary to make it valid and enforceable while preserving the original intent of the Parties to the fullest extent permitted by law; and (b) the remaining provisions of this Agreement shall in no way be affected or impaired thereby and shall remain in full force and effect. Any waiver or failure to enforce any provision of this Agreement on one occasion will not be deemed a waiver of any other provision or of such provision on any other occasion. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Execution and delivery of this Agreement may be evidenced by electronic signatures. Any notice required or permitted by this Agreement will be made in writing and be deemed delivered upon verification of delivery to the other Party. This Agreement will bind and inure to the benefit of each Party’s permitted successors and assigns. Neither Party may assign this Agreement or any of its rights or obligations hereunder without the advance written consent of the other Party, except that either Party may assign this Agreement and all of its rights and obligations hereunder without such consent to (a) an Affiliate; or (b) a successor entity in connection with a merger, reorganization, acquisition or other transfer of all or substantially all of such Party’s assets or voting securities. Any attempt to transfer or assign this Agreement except as expressly authorized under this Section will be null and void. The person executing this Agreement on behalf of each Party represents that he or she has the requisite legal authority to enter into this Agreement on behalf of the Party and bind that Party to the terms and conditions of this Agreement, and each Party understands that the other Party is relying on this representation in entering into this Agreement.
14. Non-Solicitation. During the term of this Agreement and for a period of 12 months after its expiration or termination, neither Party will, directly or indirectly, solicit for employment or engagement any employee or key independent contractor of the other Party or its Affiliates who became known to the soliciting Party in connection with the Permitted Use, without the prior written consent of the other Party; provided, however, that nothing in this Section will prohibit (a) general solicitations of employment or engagement not specifically directed at such persons, including general advertisements and job postings, or the hiring or engagement of any person who responds thereto; or (b) the hiring or engagement of any person who contacts the soliciting Party on his or her own initiative without any direct or indirect solicitation by the soliciting Party.
Platform recording notice (not part of the Agreement text): Signing constitutes your electronic signature on this Agreement. Your signature is recorded together with your account email, the date and time, and network and session information, and that record may be used in any proceeding to enforce this Agreement. Providing a false identity or signing without authority is itself actionable, so please sign accurately; it protects everyone at this table.
Your information is encrypted in transit and at rest. Signed records include your account, timestamp, and network and session information.
Plans & Pricing
Choose Medication
Catalog
Projections
Organization Policies
Review & Sign
Company Info
Pricing & Model
Formulary Ingest
Policy Compliance
About TEHR
Every telehealth brand you envy runs on infrastructure you cannot see. TEHR is that infrastructure: the provider network, e-prescribing with EPCS, a national compounding and commercial pharmacy stack, compliant payment rails, and the operational machine that binds them together. All of it wearing your brand. Your patients never see us. Your competitors never catch you.
While others spend a year and seven figures building what breaks, you launch in 24 hours on rails that already move real prescriptions every day. You keep your identity. You keep your patients. You keep your economics. We make the machine run.
The brands winning this market did not build harder. They built on better rails.
Build your business
Pick your verticals. Each tile is a complete, ready-to-sell product line: medications, protocols, and pricing, curated and compliant out of the box. Your combination sets your monthly, and you can add tiles any time.
Add-ons
Optional. Add now or any time later; both appear in your proposal.
LegitScript Certification Fast Track iWhat this is. TEHR prepares and manages your entire LegitScript healthcare certification application: policies, documentation, and submission, riding TEHR's certified-platform status, submission-ready in 7 business days. Because TEHR holds a LegitScript enterprise account, you onboard through our enterprise code: the standard $975 application fee is waived, and the $2,500 expedited-processing fee most brands pay to move quickly becomes unnecessary. Going alone, first-year cost runs $3,125 to $5,625 paid to LegitScript before anyone has prepared your application. Through TEHR you pay LegitScript only its annual certification fee ($2,150, paid directly to LegitScript). Certification is not mandatory, but it is required to advertise your brand on Meta, Google, and TikTok.
Get certified to advertise on Meta, Google, and TikTok. We build and manage the whole application, and you onboard through TEHR's LegitScript enterprise code: the $975 application fee is waived. LegitScript's annual certification fee is itemized separately and paid to LegitScript.
$2,499 one-time
Patient Support Coordinators (PSC) iWhat this is. A dedicated, trained support team answering as your brand: intake and questionnaire help, order status and shipping questions, refill and renewal coordination, pharmacy and payment issue resolution, and refund handling under your published policy. Clinical questions are never answered by PSCs; they are routed to the independent Medical Group, keeping the clinical boundary clean. Your team is ramped on your scripts, knowledge base, and escalation paths (one-time ramp fee in your proposal), then metered on your exact active patient count each month. PSC scales with the patients you serve; your plan reflects the catalog you offer.
Your entire patient support desk, run by TEHR and answering as your brand: order status, refills, shipping, billing, and intake help, with clinical questions routed to the Medical Group. $2 per active patient per month for your first 1,000 patients, then $1 thereafter, plus a one-time ramp fee in your proposal.
Metered monthly
$0/mo
Save your plan and we build your starting catalog automatically: a curated, ready-to-sell medication set for each vertical you picked. Adjust anything in Catalog before launch.
Building without outside capital? Each quarter, TEERx Inc. partners with a small number of brands, carrying their platform costs in exchange for an equity partnership. I would like to be considered
›
All pharmacies
Blueprints:
Pricing strategy:
★ TEHR Recommended
Growth
Premium
Global adjust0%
◈
Medication
Category
Cadence
Price
Health
Lab
Model your catalog in three steps
Pick a category or search the 2,000+ medication formulary
Select a medication to see its full protocol economics
Add to your deal model and run a five-year projection
Every figure already includes TEHR's flat per-transaction fees.
Your Catalog
Build your medication menu. When ready, submit to TEHR for onboarding.
Submission History
Medication
Category
Patient Price
Activation
Membership/mo
Cycles/yr
Lab
Year 1 Net
Year 2+ Net
Submit Catalog to TEHR
Send your catalog to the TEHR onboarding team for processing. They'll generate the upload template and load your products.
Required. Your assigned 1-3 letter organization identifier.
Up to 1,000 characters.
Review & Sign
Everything you have built, in one place. Review it, execute your agreement, and your organization moves to activation.
Your agreement
One page. One flat platform fee per processed transaction, card processing at the platform's standard rate. The full Master Services Agreement is incorporated by reference and available for your counsel at any time.
Activation
Organization Policies
Two documents, one working session. Pick your refund rule, paste your Terms and Privacy Policy, publish. Have a licensed attorney review both before you publish; TEHR provides tooling and reference points, not legal advice.
More about how this worksEach panel outlines what the document should cover, informed by current federal enforcement practice, with one-tap inserts describing the platform and billing structure. Clinical documents (Telehealth Informed Consent, HIPAA Notice, product consents) belong to the independent Medical Group serving your patients and are presented automatically at checkout; you never draft or edit them. Drafts save automatically in this browser.
Step 1 · Pick your refund rule (most teams keep the defaults)
One source of truth
Choose the rule; the platform computes the numbers from the amounts disclosed to the patient at purchase, so your contract and your billing engine can never disagree. No fee amounts are hardcoded in your Terms.
Clinical disqualification
Disqualification always follows intake, labs (if needed), and provider review, so deductions reflect care actually delivered.
Refund after services
This covers a patient who clinically qualified and received services, then requests a refund, whether before or after their medication ships. Shipped medications are never refunded; your rule above governs everything else on the order.
Administrative fee iYour flat, disclosed patient-side fee on refunds. One number, shown to the patient at checkout. It offsets your typical costs when a sale refunds; on any single refund you may be slightly ahead or behind, and it evens out across your catalog. TEHR and TRIMUS never charge you this fee.
Your protection at each refund stage(how much of the sale a refund cannot claw back)
On a normal completed sale, none of these numbers exist anywhere; your margin is exactly what Projections shows. These amounts appear only when a patient refunds, and every dollar here is a dollar the refund cannot claw back: your administrative fee stays with you, and the clinical amounts pay the independent Medical Group for care already delivered under its own patient contract, so a refund never unwinds work that actually happened. Shown to the patient at checkout; never charged to your organization.
Shipped medications are never returned or refunded (platform default, stated in your generated language).
Reference · How the money moves, and why this structure protects you
Patients pay through TRIMUS. Clinical care for your patients is delivered by an independent, physician-owned Medical Group already integrated with the platform; you do not need to bring or form a medical practice. TRIMUS serves as billing agent and merchant of record on the Medical Group's behalf, fronts all payment processing, and executes every refund from the same rails, so when a refund, cancellation, or clinical disqualification occurs, the patient is made whole under the policy you selected above without your organization touching the transaction.
Platform fees settle themselves. The per-transaction Technology and MSO fees accrue when a transaction is processed and are deducted automatically at settlement from amounts otherwise payable to your organization, never added to the patient's price or shown on their receipt. They are due regardless of clinical outcome, prescription issuance, patient refund, cancellation, or disqualification. On refunded transactions, where the patient has been made whole and there is no settlement to deduct from, the fee is covered by a modest reserve your organization maintains on its connected account; any shortfall is collected automatically or invoiced. TRIMUS has already carried the cost of processing that transaction either way, and the fee is how the platform recovers it, with no monthly bill to reconcile and no surprises.
Card processing is the third lane. Card processing is charged at the platform's standard processing rate, stated in your fee schedule, and appears as its own line on your settlement ledger. One detail worth knowing up front: processing fees are not returned when a payment is refunded, so a refunded order carries its processing and platform fees with no settlement to net them against. That is exactly what your reserve is sized to absorb, and it is why nothing about a refund ever shows up as a surprise. These costs are never itemized to patients; organizations typically recover them in pricing or the administrative fee.
This is deliberate, and it works in your favor. Because the fee never varies with what a provider decides, it is structurally never payment for prescribing. That fixed, outcome-blind design is what keeps your platform fees clean under federal fee-splitting and anti-kickback analysis, keeps your patient pricing entirely yours, and gives you an audit trail where every fee traces to a processed transaction rather than a clinical result.
Recovering the cost is your choice. The optional administrative fee above is how you recover platform costs on refunded orders if you wish, disclosed to patients at checkout. Many organizations simply absorb them as a customer-experience investment. Either way, the fee owed to the platform does not change, so there is never a surprise on your settlement ledger. One flat fee per transaction, clinical fees riding the patient price, and no percentage of your revenue anywhere: the net you model in this calculator is the net you keep.
Step 2 · Paste your two documents and publish
Work top to bottom: review what belongs in each document, paste or draft with your attorney, insert the platform descriptions, then run checks and publish. Your refund policy from Step 1 powers the Refund and fee schedule insert.
Policy Compliance ADMIN
Every organization policy publish recorded centrally: document, version, hash, and the signed confirmation of authorship. Immutable; server-timestamped.
Loading...
Formulary Ingest ADMIN
Upload a TEHR-FULL-INGEST CSV. The file is validated in your browser (structure, duplicates, margin floor, DoseSpot character rules) before anything leaves this page. A dry run shows the server diff; nothing is applied until you confirm.
About TEHR
Every telehealth brand you envy runs on infrastructure you cannot see. TEHR is that infrastructure: the provider network, e-prescribing with EPCS, a national compounding and commercial pharmacy stack, compliant payment rails, and the operational machine that binds them together. All of it wearing your brand. Your patients never see us. Your competitors never catch you.
While others spend a year and seven figures building what breaks, you launch in 24 hours on rails that already move real prescriptions every day. You keep your identity. You keep your patients. You keep your economics. We make the machine run.
The brands winning this market did not build harder. They built on better rails.
How pricing works
Two components, both flat. A platform subscription based on the medications and categories you choose to offer through your brand: your tier reflects the clinical and regulatory workload of your catalog, not how many patients you serve. Prescribing decisions always rest with the licensed providers in the TEHR network. And a flat, fixed fee per patient transaction: every visit, consult, and fulfillment carries the same fee whether or not a prescription results. It covers the work each transaction creates: intake, provider routing, clinical review, eRx when issued, fulfillment coordination, and payment orchestration. TEHR never takes a percentage of your revenue, and because the fee is identical with or without a prescription, it is never payment for prescribing. The effective cost falls as you grow.
Patient Support Coordinators (PSC)
TEHR can run your entire patient customer service through dedicated Patient Support Coordinators. PSC support is an optional add-on, metered on your exact active patient count each month: $2 per active patient per month for your first 1,000 patients, then $1 per active patient thereafter, plus a one-time ramp fee for brand onboarding (scripts, knowledge base, escalation paths) presented in your proposal. Tiers are based on your medication catalog, not patient count: your platform tier reflects the clinical and regulatory workload of the catalog you offer, while PSC scales with the patients you serve.
Tier subscription pricing, the PSC ramp fee, and the per-transaction fee schedule are presented in your TEHR proposal and contract. Card processing (2.9% + $0.31 per charge) and optional lab panels are pass-through costs, itemized separately. All modeling in this tool already includes the flat transaction fees.
Company Information
This is collected exactly as TEHR's organization setup requires, we use it verbatim to create your organization inside the platform. You can update and re-save it any time; the latest version rides your next catalog submission. Fields marked * are required before you can submit a catalog.
Basic Information :
Address :
Billing & Contact Details : *
Any formal correspondence is mailed here, use a real, monitored address where we can reach you if needed.
Organization Owners: *
Organization Admins: *
At least one Organization Admin is required, this is the person who will verify their identity at onboarding and administer your organization inside TEHR.
Customer Support Address :
5-Year Revenue Projections
Project annual net revenue across your entire saved catalog using assumed patient base, monthly churn rate, and annual growth.
⚠ Modeling-only disclaimer
This is a forward-looking revenue projection based on assumptions you've supplied (patient pricing, cycle frequency, churn rate, growth rate). Actual results depend on patient acquisition costs, market conditions, operator execution, regulatory factors, and many variables not modeled here.
Projections are for planning purposes only and constitute neither a guarantee nor a representation of expected returns. Output is not for redistribution.
≈ 46% annual
≈ 101% annual
$
Marketing cost to acquire one patient; subtracted per new patient.
Select 2+ medications from the same pharmacy with the same days supply. A bundle ships once and carries one platform fee (the highest tier in it).
Not every patient buys every medication. Set the % of your patient base who buy each SKU. Defaults split each category's expected penetration across the protocols you saved in that category, since a patient chooses one protocol, not all of them. Adjust any row. These don't change your saved catalog.
Medication
Category
Patient price
Attach %
Buying patients
The TEHR model: simple, transparent, flat
TEHR charges a flat, fixed fee per patient transaction, never a percentage of your revenue. Every visit, consult, and fulfillment carries the same fee whether or not a prescription results, so the fee is never payment for prescribing. Those flat fees are already included in every net figure above.
Platform subscription tier derived from your catalog: - (Launch · Growth · Scale · Custom. Tier pricing presented in your TEHR proposal.).